Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VOR compared with AURA: revenue, margins and what each company keeps, and the suppliers and customers both name
VOR
Vor Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
AURA
Aura Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
VOR
Vor Biopharma Inc.
vs
AURA
Aura Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
VOR: latest quarter not drawable. AURA: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VOR
3
—
RemeGen
unlisted
supplier
—
The Trustees of Columbia University in the City of New York
unlisted
customer
—
U.S. Department of Health and Human Services, as represented by National Cancer Institute of the National Institutes of Health
unlisted
customer
Shared
0
No disclosed counterparties: AURA.
Only AURA
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
VOR, solid
AURA, dashed
VOR
Vor Biopharma Inc.
Change
20.02
▲
+0.83%
Mkt cap
$1.2B
AURA
Aura Biosciences, Inc.
Change
6.29
▲
+0.73%
Regular session
Nov 4 '26
Mkt cap
$625.3M
vs
Compare
Regular session
Nov 4 '26
VOR
Vor Biopharma Inc.
vs
AURA
Aura Biosciences, Inc.
20.02
▲
+0.83%
Price
6.29
▲
+0.73%
$1.2B
Mkt cap
$625.3M
Change
Change
VOR
20.02
▲
+0.83%
vs
AURA
6.29
▲
+0.73%
Regular session
Nov 4 '26